Navigation Links
Rib-X Pharmaceuticals Announces Presentations at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Date:5/7/2009

NEW HAVEN, Conn., May 7 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, today announced that researchers will be presenting two presentations and two posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) taking place in Helsinki, Finland from May 16-19, 2009.

Independent researchers, Dr. Franciose van Bambeke and Dr. Sandrine Lemaire, both from Universite Catholique de Louvain, will each make oral presentations describing the unique microbiological and pharmacodynamic properties of Rib-X's novel oxazolidinone, radezolid, during a session entitled Pharmacokinetics/Pharmacodynamics: Clinical Relevance, on Saturday, May 16th.

Additionally, Rib-X researchers will be presenting two posters on delafloxacin, one of which discusses the activity and efficacy of delafloxacin in a Phase 2 clinical trial for complicated Skin and Skin Structure Infections. The second poster session details the in vitro activity of delafloxacin against a large, worldwide panel of methicillin-resistant Staphylococcus aureus. 

    Details on the presentations and abstracts are as follows:

     Date        Time    Session          Title                Location/Poster

    May 16,    3:06pm -   PK/PD:     The novel oxazolidinone   Lecture Hall 3a
     2009      3:18pm     Clinical   radezolid (RX-1741)
                          Relevance  accumulates in THP-1
                                     macrophages: comparative
                                     studies with linezolid
                                     and azithromycin.

    May 16,    3:18pm -   PK/PD:     Radezolid (RX-1741), a    Lecture Hall 3a
     2009      3:30pm     Clinical   novel oxazolidinone, is
                          Relev
'/>"/>
SOURCE  Rib-X Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 

Related biology technology :

1. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing
2. Rib-X Pharmaceuticals to Present at the 2008 ICAAC/IDSA Joint Meeting
3. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
4. Rib-X Pharmaceuticals to Present at Cambridge Healthtech Institutes 2nd Annual Challenge of Antibacterial Development Conference
5. Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
6. Optimer Pharmaceuticals Reports First Quarter 2009 Financial Results
7. Savient Pharmaceuticals Reports First Quarter 2009 Financial Results
8. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, May 11, 2009
9. Cadence Pharmaceuticals CEO Ted Schroeder to Present at Two Investment Conferences During the Month of May 2009
10. Amylin Pharmaceuticals Announces a New Sales Approach to Better Target the Diabetes Market
11. First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals GGTI-2418
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... The congress of the ERA-EDTA ... the biggest congress in Europe ... are in Istanbul to share ... pioneering studies have been presented: / (1) ... VIA HEMODIALYSATE REDUCES ESA USE" By SFP-iron ...
(Date:5/21/2013)... 21, 2013 Smarter Security, Inc., provider ... today announced that Genzyme, a Sanofi company and leading ... Detective® CL for a multi-use facility in the United ... other Genzyme buildings, this latest order underscores the satisfaction ... tailgate detection device improving doorway access control. ...
(Date:5/21/2013)... Many have long discussed the link between ... physicians from Clinical Psychiatry.com readdressed the topic ... and suggested using hypnotherapy and other mental ... stress that cause acne. , Doctors in the article ... about, stress causes changes in the skin that have ...
(Date:5/21/2013)... -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics ... announced today that Jeffrey Riley , CEO, ... MicroCap Conference on Thursday, May 30, 2013 in ... Mr. Riley is scheduled to present at 10:00 a.m. (Eastern ... can be accessed by logging onto the web at ...
Breaking Biology Technology:ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 2ERA-EDTA CONGRESS 2013: Late Breaking Clinical Trials 3Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2
... COSTA MESA, Calif., March 26 Oxygen Biotherapeutics, Inc. ... has added clinical trial sites in Israel for the ... traumatic brain injury (TBI). Oxycyte is the company,s perfluorocarbon ... addition to those previously planned for Switzerland."Israeli physicians are ...
... Renewable fuels provider New Generation Biofuels Holdings, ... today announced that it is has signed a sales ... Maryland to supply up to 370,00 gallons of renewable ... and environmentally aware company like Catoctin Mountain Growers with ...
... March 26 Micromet, Inc. (Nasdaq: MITI ... the treatment of cancer, inflammation and autoimmune diseases, today ... will present at the Future Leaders in the Biotech ... Center in New York City on Thursday, April 2, ...
Cached Biology Technology:Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel 2New Generation Biofuels Signs Sales Contract with Catoctin Mountain Growers to Supply up to 370,000 gallons of Renewable Biofuel 2New Generation Biofuels Signs Sales Contract with Catoctin Mountain Growers to Supply up to 370,000 gallons of Renewable Biofuel 3Micromet to Present at the Future Leaders in the Biotech Industry Conference on April 2, 2009 2Micromet to Present at the Future Leaders in the Biotech Industry Conference on April 2, 2009 3
(Date:5/21/2013)... increasingly being considered in the management of natural ... that can help them recognize and respond to ... their lives. , Place-Based Conservation: Perspectives from ... the Pacific Northwest Research Station,s Linda Kruger, can ... The book is published by Springer Verlag and ...
(Date:5/21/2013)... body, stem cells in the blood often jump ... immune cells that can fight off illness. But ... populations, potentially leading to the development of serious ... of researchers led by biologists at the California ... mouse models, the molecule microRNA-146a (miR-146a) acts as ...
(Date:5/21/2013)... new method for delivering molecules into single, targeted ... The technique could find applications in drug delivery, ... electroporation a technique used to deliver molecules ... membrane that are caused by exposing them to ... of cell transfection. (Cell transfection is the introduction ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Single-cell transfection tool enables added control for biological studies 2
... between Plant Physiology and The Arabidopsis Information Resource (TAIR) ... genetic and molecular data on Arabidopsis published in the ... collaborationthe first of its kind-- provides authors with the ... and gene information to the TAIR database at the ...
... are natural filters that help remove and transform pollutants ... human activities. Scientists know this as a result of ... dirty, at least very wet -- monitoring streams nationwide. ... reduces the potential for eutrophication the excessive growth ...
... 12, 2008 Tiny organisms play a powerful role in ... activity, in streams, according to a study by a team ... In the first phase of the study, which involved ... small amounts of an uncommon non-radioactive isotope of nitrogen to ...
Cached Biology News:Plant Physiology and TAIR partnership will provide genetic information to public database 2Plant Physiology and TAIR partnership will provide genetic information to public database 3Streams natural filters, if not overloaded 2ORNL study finds rivers play part in removing nitrogen 2
... peptides are molecules of peptidic nature or ... activity which can be developed at the ... agro-food applications. In this way it is ... properties for therapeutic applications. Primm offers a ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Material: ...
... forced convection Temperature range 5 C / ... / 212 F Patented APT.line preheating chamber ... controller Timer 0 to 24 h ... tenth of a degree Independent adjustable temperature ...
... Maximize the value of your microarray ... offer the support you need from ... the most up to date methods. ... the Gene Expression Profiling Service or ...
Biology Products: